House dust mite immunotherapy in Germany: real-world adherence to a subcutaneous allergoid and a sublingual tablet
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2197-0378
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
House dust mite immunotherapy in Germany: real-world adherence to a subcutaneous allergoid and a sublingual tablet ; day:17 ; month:12 ; year:2020 ; pages:1-9
Allergo journal international ; (17.12.2020), 1-9
- Creator
-
Vogelberg, C.
Brüggenjürgen, B.
Richter, H.
Jutel, M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40629-020-00155-1
- URN
-
urn:nbn:de:101:1-2021012412253496408094
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vogelberg, C.
- Brüggenjürgen, B.
- Richter, H.
- Jutel, M.
- SpringerLink (Online service)
Other Objects (12)
New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ® tablets
Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis
Allergen immunotherapy in house dust mite-associated allergic rhinitis: efficacy of the 300 IR mite tablet
Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
Clinical performance of house-dust-mite-specific subcutaneous immunotherapy in a postmarket noninterventional setting
Biology of house dust mites and storage mites
CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens
Decreased Basophil Activation against House Dust Mite after Japanese Cedar Pollen Subcutaneous Immunotherapy: A Retrospective Study
Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
Allergens from house dust and storage mites
New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ® tablets
Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis
Allergen immunotherapy in house dust mite-associated allergic rhinitis: efficacy of the 300 IR mite tablet
Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
Clinical performance of house-dust-mite-specific subcutaneous immunotherapy in a postmarket noninterventional setting
Biology of house dust mites and storage mites
CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens
Decreased Basophil Activation against House Dust Mite after Japanese Cedar Pollen Subcutaneous Immunotherapy: A Retrospective Study
Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
Allergens from house dust and storage mites
New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ® tablets
Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis
Allergen immunotherapy in house dust mite-associated allergic rhinitis: efficacy of the 300 IR mite tablet
Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
Clinical performance of house-dust-mite-specific subcutaneous immunotherapy in a postmarket noninterventional setting
Biology of house dust mites and storage mites
CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens
Decreased Basophil Activation against House Dust Mite after Japanese Cedar Pollen Subcutaneous Immunotherapy: A Retrospective Study
Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients